KalVista Investigative Site

Frankfurt am Main 60596

0 studies enrolling now · 2 studies all time

What they study most

Angioedema, Hereditary, Types I and II, Hereditary Angioedema

Studies at this site

• Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II — Completed
• A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II — Stopped early